Results 201 to 210 of about 353,121 (342)

Natural History of Alternating Hemiplegia of Childhood: Vulnerabilities in Early Childhood and Predictive Factors for Long‐Term Outcomes

open access: yesAnnals of the Child Neurology Society, EarlyView.
ABSTRACT Objective The natural history of the most common ATP1A3‐related disease, alternating hemiplegia of childhood (AHC), has not been determined. We investigated three hypotheses: (1) AHC worsens over time; (2) several novel factors correlate with long‐term outcomes; and (3) AHC manifests high mortality.
Shital H. Patel   +31 more
wiley   +1 more source

Comprehensive multi-omics mapping of immune perturbations in autism spectrum disorder. [PDF]

open access: yesClin Transl Med
Yan C   +12 more
europepmc   +1 more source

Speed‐Dependent Visual‐Motor Tracking Differences in Children With Autism Relate to Core Symptoms

open access: yesAnnals of the Child Neurology Society, EarlyView.
ABSTRACT Background and Objectives Children with autism spectrum disorder (ASD) often experience challenges integrating visual information to guide motor behavior, particularly in dynamic (speeded) contexts. We investigated the effects of varying stimulus tracking speed on visual‐motor integration (VMI), addressing our hypothesis that ASD diagnosis and
Daniel E. Lidstone, Stewart H. Mostofsky
wiley   +1 more source

Lesions Associated With Autism Symptoms Map to a Cerebellar Brain Network in Tuberous Sclerosis Complex

open access: yesAnnals of the Child Neurology Society, EarlyView.
ABSTRACT Objective Autism spectrum disorder (ASD) affects 1 in 36 individuals in the United States and is characterized by impaired social communication and restrictive/repetitive behaviors. Individuals with tuberous sclerosis complex (TSC) have a high incidence of ASD (40%) and exhibit congenital brain lesions (tubers), offering a unique lesion‐based ...
Wendy Xiao Herman   +10 more
wiley   +1 more source

Exploration of Homocysteine Metabolism and Genetics in Autism Spectrum Disorder. [PDF]

open access: yesNutrients
Rouphael M   +6 more
europepmc   +1 more source

Cannabidiol in autism: Clinical pharmacology priorities for trial design

open access: yes
British Journal of Clinical Pharmacology, EarlyView.
Gislei Frota Aragão   +2 more
wiley   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

open access: yesEnvironmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons   +17 more
wiley   +1 more source

User involvement in digital mental health: approaches, potential and the need for guidelines

open access: yesFrontiers in Digital Health
Sylvie Bernaerts   +6 more
doaj   +1 more source

An overview of oxytocin integrative mechanisms in autism spectrum disorder. [PDF]

open access: yesDiscov Ment Health
Lal N   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy